PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XPEL vs. CPRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between XPEL and CPRX is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

XPEL vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XPEL, Inc. (XPEL) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

500.00%1,000.00%1,500.00%2,000.00%JulyAugustSeptemberOctoberNovemberDecember
1,900.00%
496.69%
XPEL
CPRX

Key characteristics

Sharpe Ratio

XPEL:

-0.40

CPRX:

0.85

Sortino Ratio

XPEL:

-0.16

CPRX:

1.39

Omega Ratio

XPEL:

0.97

CPRX:

1.18

Calmar Ratio

XPEL:

-0.43

CPRX:

0.92

Martin Ratio

XPEL:

-1.10

CPRX:

3.50

Ulcer Index

XPEL:

26.75%

CPRX:

9.83%

Daily Std Dev

XPEL:

73.68%

CPRX:

40.24%

Max Drawdown

XPEL:

-99.77%

CPRX:

-94.25%

Current Drawdown

XPEL:

-60.55%

CPRX:

-9.74%

Fundamentals

Market Cap

XPEL:

$1.20B

CPRX:

$2.63B

EPS

XPEL:

$1.75

CPRX:

$1.18

PE Ratio

XPEL:

24.83

CPRX:

18.70

Total Revenue (TTM)

XPEL:

$418.41M

CPRX:

$460.48M

Gross Profit (TTM)

XPEL:

$174.59M

CPRX:

$379.07M

EBITDA (TTM)

XPEL:

$72.41M

CPRX:

$192.55M

Returns By Period

In the year-to-date period, XPEL achieves a -25.72% return, which is significantly lower than CPRX's 28.49% return. Over the past 10 years, XPEL has outperformed CPRX with an annualized return of 32.41%, while CPRX has yielded a comparatively lower 22.05% annualized return.


XPEL

YTD

-25.72%

1M

-12.53%

6M

11.73%

1Y

-28.77%

5Y*

22.14%

10Y*

32.41%

CPRX

YTD

28.49%

1M

0.56%

6M

40.35%

1Y

30.28%

5Y*

40.23%

10Y*

22.05%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

XPEL vs. CPRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for XPEL, Inc. (XPEL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for XPEL, currently valued at -0.40, compared to the broader market-4.00-2.000.002.00-0.400.85
The chart of Sortino ratio for XPEL, currently valued at -0.16, compared to the broader market-4.00-2.000.002.004.00-0.161.39
The chart of Omega ratio for XPEL, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.18
The chart of Calmar ratio for XPEL, currently valued at -0.43, compared to the broader market0.002.004.006.00-0.430.92
The chart of Martin ratio for XPEL, currently valued at -1.10, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.103.50
XPEL
CPRX

The current XPEL Sharpe Ratio is -0.40, which is lower than the CPRX Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of XPEL and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JulyAugustSeptemberOctoberNovemberDecember
-0.40
0.85
XPEL
CPRX

Dividends

XPEL vs. CPRX - Dividend Comparison

Neither XPEL nor CPRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

XPEL vs. CPRX - Drawdown Comparison

The maximum XPEL drawdown since its inception was -99.77%, which is greater than CPRX's maximum drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for XPEL and CPRX. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-60.55%
-9.74%
XPEL
CPRX

Volatility

XPEL vs. CPRX - Volatility Comparison

XPEL, Inc. (XPEL) has a higher volatility of 11.04% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 9.00%. This indicates that XPEL's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
11.04%
9.00%
XPEL
CPRX

Financials

XPEL vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between XPEL, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab